About this webinar
Medication can be confusing and difficult to manage. The average person wastes hours each year filling their prescriptions. And worse, in Trinidad and Tobago, one in two people don’t even bother filling their prescriptions. When Kiran Mathur Mohammed and Edward Inglefield struggled to manage their grandparents’ life-saving medication, they developed a game-changing solution: medl.
Join us for a live webinar with Kiran and Edward, co-founders of medl, as they take us through how medl was created, the challenges and successes they experienced as a fast-growing startup, and how they’re driving the future of pharmacy. medl was also recently selected from more than 500 solutions to receive COVID-19 grant funding from the IDB Lab to generate a larger impact across Latin America and the Caribbean.
We’ll also get a hands-on demo of medl’s end-to-end platform that connects doctors and patients to dispense and deliver medication, as well as an overview of how DrugBank’s Clinical API is used to enable accurate medication entry and identify drug-drug interactions and adverse effects.
The Powered by DrugBank webinar series showcases our innovative customers and how they integrate DrugBank in their applications. Follow us on social media and stay tuned to hear more about this series.
Edward is co-founder of medl and has worked at TouchPoint, an online advertising tech solution; Carib Brewery in marketing; and at Mercedez-Benz as an apprentice. He co-directed a documentary: “A Quiet Revolution”, which won the keynote award in the Trinidad & Tobago Green Screen film festival.
Social entrepreneur and co-founder of medl, Kiran is also a columnist at the Trinidad Newsday and holds a directorship at Imjin Security. As a development economist, Kiran has also worked in the finance and non-profit spheres in the private and public sectors in Latin America and the Caribbean.
Michael Wilson is CEO and co-founder of DrugBank. Mike graduated with a Bachelor of Science in Biological & Computer Sciences in 2012, and has been a foundational part of DrugBank since December 2015. His research and expertise lies in metabolomics, bioinformatics, as well as company operations.
DrugBank's powerful tools and structured pharmaceutical knowledge base enables advances in drug discovery, drug repurposing, precision medicine and healthcare delivery.
Share this event